Home
>
National Drug Code (NDC)
>
HIBERIX
HIBERIX - 58160-806-05 - (Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate))
Drug Information of HIBERIX
| Product NDC: | 58160-806 |
| Proprietary Name: | HIBERIX |
| Non Proprietary Name: | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
| Active Ingredient(s): | 10 ug/.5mL & nbsp; Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of HIBERIX
| Product NDC: | 58160-806 |
| Labeler Name: | GlaxoSmithKline Biologicals SA |
| Product Type: | VACCINE |
| FDA Application Number: | BLA125347 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090824 |
Package Information of HIBERIX
| Package NDC: | 58160-806-05 |
| Package Description: | 10 VIAL in 1 CARTON (58160-806-05) > .5 mL in 1 VIAL (58160-806-01) |
NDC Information of HIBERIX
| NDC Code | 58160-806-05 |
| Proprietary Name | HIBERIX |
| Package Description | 10 VIAL in 1 CARTON (58160-806-05) > .5 mL in 1 VIAL (58160-806-01) |
| Product NDC | 58160-806 |
| Product Type Name | VACCINE |
| Non Proprietary Name | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20090824 |
| Marketing Category Name | BLA |
| Labeler Name | GlaxoSmithKline Biologicals SA |
| Substance Name | HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN |
| Strength Number | 10 |
| Strength Unit | ug/.5mL |
| Pharmaceutical Classes | Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
